H syndrome: novel and recurrent mutations in SLC29A3.

Article Details

Citation

Priya TP, Philip N, Molho-Pessach V, Busa T, Dalal A, Zlotogorski A

H syndrome: novel and recurrent mutations in SLC29A3.

Br J Dermatol. 2010 May;162(5):1132-4. doi: 10.1111/j.1365-2133.2010.09653.x. Epub 2010 Feb 25.

PubMed ID
20199539 [ View in PubMed
]
Abstract

The H syndrome (OMIM 612391) is a recently described autosomal recessive disorder characterized by cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, short stature (low height), hyperglycaemia/diabetes mellitus, hallux valgus, and fixed flexion contractures of the toe and finger joints.(1,2) Histologically, there is an inflammatory infiltrate consisting mainly of histiocytes, later replaced by fibrosis of the deep dermis and subcutis.(3) In total, 31 patients have been reported in the literature with the clinical phenotype characteristic of this syndrome.(1-7)

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Equilibrative nucleoside transporter 3Q9BZD2Details